The cell-free protein expression market is expected to experience growth by 2034, with some reports suggesting it could reach a value of $716.26 million. Related markets, such as recombinant protein and plasmid dna manufacturing, are also anticipated to see significant growth, with projected values and compound annual growth rates (CAGRs) varying by market. The overall biotechnology sector appears poised for expansion, with multiple related markets expected to surge in value by 2034.